ESC/EAS Guidelines for the management of dyslipidaemias

Cites (222)

Items 201–222 of 222

1. Ezetimibe Alone Reduces Low‐Density Lipoprotein Cholesterol in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy
   David Alain Wohl, David D. Waters, Ross J. Simpson, Susan Richard, Amanda Schnell, Sonia Napravnik, Jessica Keys, Joseph J. Eron, Priscilla Y. Hsue · 2008 · Clinical Infectious Diseases
2. The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment
   Hyre, Amanda D., Fox, Caroline S., Astor, Brad C., Cohen, Andrew J., Muntner, Paul · 2007 · American Journal of Kidney Diseases
3. Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus
   Thorburn, Christine M., Ward, Michael M. · 2003 · Arthritis & Rheumatism
4. The use of Meta‐Analysis Risk Estimates for Candidate Genes in Combination to Predict Coronary Heart Disease Risk
   Fotios Drenos, John C. Whittaker, Steve Eric Humphries · 2007 · Annals of Human Genetics
5. Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)
   Ingar Holme, Nilo B. Cater, Ole Færgeman, John J.P. Kastelein, ANDERS G. OLSSON, Matti J. Tikkanen, Mogens Lytken Larsen, Christina Lindahl, Terje Rolf Pedersen, on behalf of the Incremental Decrea · 2008 · Annals of Medicine
6. Safety evaluation of phytosterol-esters. Part 9: results of a European post-launch monitoring programme
   Lea, L.J., Hepburn, P.A. · 2006 · Food and Chemical Toxicology
7. Cholesterol and cardiovascular disease
   Tyroler, H.A. · 1984 · The American Journal of Cardiology
8. Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis treatment study (FATS), the HDL-Atherosclerosis treatment study (HATS) and the Armed Forces regression Study (AFREGS)
   Zhao, Xue-Qiao, Krasuski, Richard A., Baer, Jefferson, Whitney, Edwin J., Neradilek, Blazej, Chait, Alan, Marcovina, Santica, Albers, John J., Brown, B. Greg · 2009 · The American Journal of Cardiology
9. Effects of rice policosanol on serum lipoproteins, homocysteine, fibrinogen and C-reactive protein in hypercholesterolaemic patients
   Reiner, ??eljko, Tedeschi-Reiner, Eugenia, Romi??, ??eljko · 2005 · Clinical Drug Investigation
10. HMG CoA reductase inhibitors (statins) for kidney transplant recipients
    Sankar Dass Navaneethan, Vlado Perkovic, David Wayne Johnson, Sagar U Nigwekar, Jonathan C. Craig, Giovanni FM Strippoli · 2009 · Cochrane Database of Systematic Reviews
11. Effect of cigarette smoking cessation on risk factors for coronary atherosclerosis
    Rabkin, S.W. · 1984 · Atherosclerosis
12. Fish oil and the management of hypertriglyceridemia
    Mattar, Melanie, Obeid, Omar · 2009 · Nutrition and Health
13. Development of a high-resolution melting method for mutation detection in familial hypercholesterolaemia patients
    Whittall, R A, Scartezini, M, Li, KaWah, Hubbart, C, Reiner, Z, Abraha, A, Neil, H A W, Dedoussis, G, Humphries, S E · 2010 · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
14. Relative safety of gemfibrozil and fenofibrate in the absence of concomitant cerivastatin use
    Holoshitz, Noa, Alsheikh-Ali, Alawi A., Karas, Richard H. · 2008 · The American Journal of Cardiology
15. Perspectives on low-density-lipoprotein cholesterol goal achievement
    Catapano, Alberico L. · 2009 · Current Medical Research and Opinion
16. The efficacy and tolerability of ezetimibe in cardiac transplant recipients taking cyclosporin
    Shaw, Steven M., Chaggar, Parminder, Ritchie, James, Shah, Mohammed K. H., Baynes, Anna C., O’Neill, Nicola, Fildes, James E., Yonan, Nizar, Williams, Simon G. · 2009 · Transplantation
17. Low-density lipoprotein apheresis as a treatment option for hyperlipidemia
    Mehta, Puja K., Baer, Jefferson, Nell, Christine, Sperling, Laurence S. · 2009 · Current Treatment Options in Cardiovascular Medicine
18. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative
    Coodley, Gregg O., Jorgensen, Maryclair, Kirschenbaum, Jack, Sparks, Chieko, Zeigler, Lisa, Albertson, Barry D. · 2008 · The American Journal of Medicine
19. Low glycaemic index diets for coronary heart disease
    Sarah A. Kelly, Carolyn Dawn Summerbell, Victoria J. Ashton, Gary Steven Frost · 2003
20. Lipids, nutrition, and coronary heart disease.
    Scott M. Grundy, Valentı́n Fuster, Rachael Ross, Eric J. Topol · 1996
21. Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus
    Levy, Philip · 2010 · Metabolic Syndrome and Related Disorders
22. HMG CoA reductase inhibitors (statins) for kidney transplant recipients
    Sankar Dass Navaneethan, Vlado Perkovic, Sagar U Nigwekar, David Wayne Johnson, Jonathan C. Craig, Giovanni FM Strippoli · 2009 · Cochrane Database of Systematic Reviews